Trials / Completed
CompletedNCT03633344
Efficacy of the Administration of Colloidal Silicon Dioxide in Tablet Dosage Form in Patients With Acute Diarrhea
Efficacy of the Administration of Colloidal Silicon Dioxide in Tablet Dosage Form (Carbowhite) in Patients With Acute Diarrhea.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Omnifarma Kiev LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate the antidiarrheal efficacy of colloidal silicon dioxide in tablet dosage form (Carbowhite) in patients with acute diarrhea.
Detailed description
Background: Diarrhea is a medical condition characterized by frequent stool, more than 3 times (and more than 5-7 times in newborns) within the last 24 hours, and/or loose stool. The fecal matter is liquid, its daily mass exceeds 200 g per day, and water content reaches 95%. Objectives: To demonstrate the antidiarrheal efficacy of colloidal silicon dioxide in tablet dosage form (Carbowhite) in patients with acute diarrhea. Methods: A randomized clinical trial, double-blind, placebo-controlled, multi-center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carbowhite | |
| DRUG | Carbowhite placebo |
Timeline
- Start date
- 2016-03-29
- Primary completion
- 2016-10-07
- Completion
- 2016-10-07
- First posted
- 2018-08-16
- Last updated
- 2019-06-06
- Results posted
- 2019-06-06
Source: ClinicalTrials.gov record NCT03633344. Inclusion in this directory is not an endorsement.